
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
[ Tue, Aug 22nd 2023 ]: WOPRAI
Ross Osborn Reiterated (XGN) at Buy and Held Target at $6 on, Aug 22nd, 2023


🞛 This publication is a summary or evaluation of another publication
Ross Osborn of Cantor Fitzgerald, Reiterated "Exagen Inc." (XGN) at Buy and Held Target at $6 on, Aug 22nd, 2023.
Ross, nor any peers, have made any analyst calls on XGN in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30